Status:
COMPLETED
Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)
Lead Sponsor:
Institut de Cancérologie de Lorraine
Conditions:
Head and Neck Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the preventio...
Eligibility Criteria
Inclusion
- Age \> or =18
- Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask
- Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment
- Patient capable and willing to follow all study procedures in accordance with the protocol
- Patient who understood the study and gave informed consent
- Patient affiliated to a social security system
Exclusion
- Contraindication to hypnosis: psychosis, schizophrenia
- Non-French speaking patient
- Significant hearing loss
- Pregnant woman, likely to be, or breastfeeding
- Persons deprived of their liberty or under guardianship (including guardianship)
- Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons
- Patient who has already received radiotherapy to the head or neck with a compression mask
Key Trial Info
Start Date :
December 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04671485
Start Date
December 16 2020
End Date
February 5 2025
Last Update
July 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, 54519
2
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, Vandoeuvre lès Nancy